U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted

The Baltimore plant that recently had to scrap up to 15 million ruined doses had flouted rules and downplayed errors, according to internal audits, ex-employees and clients. Other doses had to be scrapped last year.

View original article
Contributor: Chris Hamby, Sharon LaFraniere and Sheryl Gay Stolberg